methotrexate has been researched along with Pheochromocytoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, BT; Perelle, BA; Perlman, RL; Vaccaro, KK | 1 |
| Arieh, YB; Better, OS; Gellei, B; Koten, A; Nahir, AM; Scharf, Y | 1 |
2 other study(ies) available for methotrexate and Pheochromocytoma
| Article | Year |
|---|---|
Studies on dihydropteridine reductase activity in pheochromocytoma cells.
Topics: Adrenal Gland Neoplasms; Dihydropteridine Reductase; Humans; Kinetics; Methotrexate; NADH, NADPH Oxidoreductases; Pheochromocytoma; Tyrosine 3-Monooxygenase | 1981 |
Prolonged survival in malignant pheochromocytoma of the organ of Zuckerkandl with pharmacological treatment.
Topics: Adrenal Gland Neoplasms; Adult; Chromaffin System; Cyclophosphamide; Female; Follow-Up Studies; Humans; Methotrexate; Neoplasm Metastasis; Phenoxybenzamine; Pheochromocytoma; Propranolol; Time Factors | 1973 |